BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+11.22%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$10.3B
AUM Growth
+$10.3B
(+14%)
Cap. Flow
+$826M
Cap. Flow
% of AUM
8.01%
Top 10 Holdings %
Top 10 Hldgs %
81.62%
Holding
101
New
12
Increased
23
Reduced
8
Closed
11
Top Buys
| 1 |
Insmed
INSM
|
$235M |
| 2 |
Summit Therapeutics
SMMT
|
$198M |
| 3 |
Alkermes
ALKS
|
$55.1M |
| 4 |
Revolution Medicines
RVMD
|
$52.5M |
| 5 |
Structure Therapeutics
GPCR
|
$44.5M |
Top Sells
| 1 |
CRISPR Therapeutics
CRSP
|
$22.3M |
| 2 |
argenx
ARGX
|
$22M |
| 3 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$17.6M |
| 4 |
TSVT
2seventy bio
TSVT
|
$12.3M |
| 5 |
Akero Therapeutics
AKRO
|
$12M |
Sector Composition
| 1 | Healthcare | 100% |
